Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A therapeutic HIV vaccine using coxsackie-HIV recombinants: a possible new strategy.

AIDS research and human retroviruses - 10 Oct 2000

Halim S S, Collins D N, Ramsingh A I

Abstract excerpt

The ultimate goal in the treatment of HIV-infected persons is to prevent disease progression. A strategy to accomplish this goal is to use chemotherapy to reduce viral load followed by immunotherapy to stimulate HIV-specific immune responses that are observed in long-term asymptomatic individuals. An effective, live, recombinant virus, expressing HIV sequences, would be capable of inducing both CTL and CD4(+)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Enterovirus
Share to Genetic Vectors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HeLa Cells

Share to HIV Core Protein p24

Share to Polyproteins

Share to Vaccines, Attenuated

Share to Vaccines, Synthetic

Source

Identifiers

PMID: 11054268
DOI: 10.1089/088922200750006074

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A therapeutic HIV vaccine using coxsackie-HIV recombinants: a possible new strategy.PMID 11054268Read ↗

Characterization of Nonpathogenic, Live, Viral Vaccine Vectors Inducing Potent Cellular Immune ResponsesSemantic proximity Read ↗

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesSemantic proximity Read ↗

Genetic mapping of the determinants of plaque morphology of coxsackievirus B4.Semantic proximity Read ↗

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vectorSemantic proximity Read ↗

Progress toward an HIV vaccine.Semantic proximity Read ↗

Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.Semantic proximity Read ↗

Novel vaccine vectors for HIV-1Semantic proximity Read ↗

Designing Recombinant Vaccines with Viral Properties: A Rational Approach to More Effective VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.